Showing results (611-620 of 1,523) with videos related to
Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|October 4, 2025
A Unified Whole Lung PBK Model for Inhalational Uptake of Gases and Aerosols in MenNorman Nowak, Sylvia E Escher, Katharina SchwarzCPT: Pharmacometrics & Systems Pharmacology|May 9, 2020
Genetic Algorithms as a Tool for Dosing Guideline Optimization: Application to Intermittent Infusion Dosing for Vancomycin in AdultsPieter J Colin, Douglas J Eleveld, Alison H ThomsonCPT: Pharmacometrics & Systems Pharmacology|June 20, 2020
A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With EliglustatRuth Abrams, Chanchala D Kaddi, Mengdi Tao, et al.CPT: Pharmacometrics & Systems Pharmacology|October 26, 2019
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive AnalysisBart A W Jacobs, Maarten J Deenen, Markus Joerger, et al.CPT: Pharmacometrics & Systems Pharmacology|September 10, 2025
Modeling and Simulation Identifies Endocytosis Uptake Rate and Fraction Unbound as Important Predictors of Oligonucleotide PharmacokineticsFelix Stader, Abdallah Derbalah, Adriana Zyla, et al.CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Model-Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic ModelsYoonjin Kim, Seung Hwan Baek, In-Jin Jang, et al.CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
Predicting Systemic and Liver Bosentan Exposure Using Physiologically-Based Pharmacokinetic ModelingMiao-Chan Huang, Julia Macente, Sofie Heylen, et al.CPT: Pharmacometrics & Systems Pharmacology|August 2, 2025
Pharmacometric Model-Based Sample Size Allocation for a Region of Interest in a Multi-Regional Phase 2 Trial: A Case Study of an Anti-Psoriatic DrugXiao Zhang, Yubo Xiao, Junyi Wu, et al.CPT: Pharmacometrics & Systems Pharmacology|May 1, 2021
Exposure-response modeling for extrapolation from adult to pediatric patients who differ with respect to prognostic factors: Application to everolimusThomas Dumortier, Günter Heimann, Martin FinkCPT: Pharmacometrics & Systems Pharmacology|July 22, 2025
Isavuconazole and Calcium Channel Blocker for Invasive Fungal Disease Accompanied With Hypertension: Evidence From the FAERS and PBPK/PD ModelJianxing Zhou, Bo Xiao, Zipeng Wei, et al.Pageof 153